Hemodialysis

New Methods and Future Technology

Editor(s): Ronco, C. (Vicenza)
Rosner, M.H. (Charlottesville, VA)

Fluid Overload in Hemodialysis and Acute Kidney Injury

Noninvasive Volume Assessment in the Emergency Department: A Look at B-Type Natriuretic Peptide and Bioimpedance Vector Analysis

Tuy T.a · Peacock F.b

Author affiliations

aDuke- NUS Graduate Medical School, Singapore, Singapore; bEmergency Medicine, The Cleveland Clinic, Cleveland, Ohio, USA

Related Articles for ""

Ronco C, Rosner MH (eds): Hemodialysis: New Methods and Future Technology. Contrib Nephrol. Basel, Karger, 2011, vol 171, pp 187–193

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Complete book

  • Immediate access to all parts of this book
  • Cover-to-cover formats may be available
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restriction for personal use
read more

Pricing depends on hard-cover price


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Fluid Overload in Hemodialysis and Acute Kidney Injury

Published online: May 23, 2011
Cover Date: 2011

Number of Print Pages: 7
Number of Figures: 1
Number of Tables: 1

ISBN: 978-3-8055-9771-5 (Print)
eISBN: 978-3-8055-9772-2 (Online)

Abstract

B-type natriuretic peptide (BNP) and bioimpedance vector analysis (BIVA) are potential methods of assessing fluid status in patients. Their speed and ease of implementation allows them to be used at the point of care. Currently, BNP is pivotal in the diagnosis and prognosis of heart failure, and is starting to be implemented in other diseases (e.g. acute coronary syndrome and end-stage renal disease). Although it can be elevated from volume-overload-induced cardiac stress, when assessing volume this method is ultimately unreliable since it lacks adequate specificity and accuracy. Alternatively, BIVA is accurate and sensitive in the detection of fluid status, but cannot be used to tell the etiology of the volume aberration. Despite being relatively new, BIVA is becoming recognized as a superior method to assess volume.

© 2011 S. Karger AG, Basel




Related Articles:


References

  1. Buckley MG, Sethi D, Markandu ND, et al: Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin Sci (Lond) 1992;83:437-444
  2. Kohse KP, Feifel K, Mayer-Wehrstein R: Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients. Clin Nephrol 1993;40:83-90
  3. Mark PB, Petrie CJ, Jardine AG: Diagnostic, prognostic, and therapeutic implications of brain natriuretic peptide in dialysis and nondialysis-dependent chronic renal failure. Semin Dial 2007;20:40-49
  4. McCullough PA, Duc P, Omland T, et al: B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 2003;41:571-579
  5. Forfia PR, Watkins SP, Rame JE, et al: Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J Am Coll Cardiol 2005;45:1667-1671
  6. Takami Y, Horio T, Iwashima Y, et al: Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Am J Kidney Dis 2004;44:420-428
  7. Lang CC, Choy AM, Henderson IS, et al: Effect of haemodialysis on plasma levels of brain natriuretic peptide in patients with chronic renal failure. Clin Sci (Lond) 1992;82:127-131
  8. Lee SW, Song JH, Kim GA, et al: Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. Am J Kidney Dis 2003;41:1257-1266
  9. Fagugli RM, Palumbo B, Ricciardi D, et al: Association between brain natriuretic peptide and extracellular water in hemodialysis patients. Nephron Clin Pract 2003;95:c60-c66
  10. Kazanegra R, Cheng V, Garcia A, et al: A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 2001;7:21-29
  11. Flemmer M, Rajab H, Mathena T, et al: Blood B-type natriuretic peptide and dialysis: present assessment and future analyses. South Med J 2008;101:1094-1100
  12. Disomma S, Magrini L, Pittoni V, et al: Usefulness of serial assessment of natriuretic peptides in the emergency department for patients with acute decompensated heart failure. Congest Heart Fail 2008;14:(suppl 1)21-24
  13. Morita T, Tei Y, Inoue S, et al: Fluid status of terminally ill cancer patients with intestinal obstruction: an exploratory observational study. Support Care Cancer 2002;10:474-479
  14. Kushner RF, Schoeller DA, Fjeld CR, et al: Is the impedance index (ht2/R) significant in predicting total body water?. Am J Clin Nutr 1992;56:835-839
  15. Ackland GL, Singh-Ranger D, Fox S, et al: Assessment of preoperative fluid depletion using bioimpedance analysis. Br J Anaesth 2004;92:134-136
  16. Uszko-Lencer NH, Bothmer F, van Pol PE, et al: Measuring body composition in chronic heart failure: a comparison of methods. Eur J Heart Fail 2006;8:208-214
  17. Piccoli A, Rossi B, Pillon L, et al: A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph. Kidney Int 1994;46:534-539
  18. Panella C, Guglielmi FW, Mastronuzzi T, et al: Whole-body and segmental bioelectrical parameters in chronic liver disease: effect of gender and disease stages. Hepatology 1995;21:352-358
  19. Piccoli A: Bioelectric impedance vector distribution in peritoneal dialysis patients with different hydration status. Kidney Int 2004;65:1050-1063
  20. Piccoli A, Rossi B, Pillon L, et al: Body fluid overload and bioelectrical impedance analysis in renal patients. Miner Electrolyte Metab 1996;22:76-78
  21. Piccoli A, Brunani A, Savia G, et al: Discriminating between body fat and fluid changes in the obese adult using bioimpedance vector analysis. Int J Obes Relat Metab Disord 1998;22:97-104
  22. Pillon L, Piccoli A, Lowrie EG, et al: Vector length as a proxy for the adequacy of ultrafiltration in hemodialysis. Kidney Int 2004;66:1266-1271
  23. Piccoli A: Bioelectric impedance measurement for fluid status assessment. Contrib Nephrol 2010;164:143-152
  24. Ott M, Fischer H, Polat H, et al: Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:20-25
  25. Paiva SI, Borges LR, Halpern-Silveira D, et al: Standardized phase angle from bioelectrical impedance analysis as prognostic factor for survival in patients with cancer. Support Care Cancer 2010;19:187-192
  26. Norman K, Stobaus N, Zocher D, et al: Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer. Am J Clin Nutr 2010;92:612-619
  27. Wirth R, Volkert D, Rosler A, et al: Bioelectric impedance phase angle is associated with hospital mortality of geriatric patients. Arch Gerontol Geriatr 2010;51:290-294
  28. Parrinello G, Paterna S, Di Pasquale P, et al: The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure. J Card Fail 2008;14:676-686
  29. Valle R, Aspromonte N, Giovinazzo P, et al: B-type natriuretic peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure. J Card Fail 2008;14:219-224
  30. Valle R, Aspromonte N, Carbonieri E, et al: Fall in readmission rate for heart failure after implementation of B-type natriuretic peptide testing for discharge decision: a retrospective study. Int J Cardiol 2008;126:400-406

Article / Publication Details

First-Page Preview
Abstract of Fluid Overload in Hemodialysis and Acute Kidney Injury

Published online: May 23, 2011
Cover Date: 2011

Number of Print Pages: 7
Number of Figures: 1
Number of Tables: 1

ISBN: 978-3-8055-9771-5 (Print)
eISBN: 978-3-8055-9772-2 (Online)


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP